u C]oleate in CE (by 70-90%) in incubations with or without added lipoproteins. The half-maximal inhibitory concentration for this effect of compactin was 30 nM. Lovastatin and simvastatin were more potent, but pravastatin was about 100-fold less potent Although compactin also caused a clear inhibition of cholesterol synthesis in the presence of acetyl LDL, the effect on CE formation did not seem to be related to decreased cholesterol synthesis, since this was already very low in the presence of acetyl LDL. Compactin did not affect the association and degradation of labeled acetyl LDL and also had no effect on the rate of cholesterol loss after preloading the cells with CE by incubation with acetyl LDL. However, compactin had a slight stimulatory effect on the synthesis of phosphatidylcholine and sphingomyelin when compactin was added to incubations in the presence of acetyl LDL. We conclude that vastatins can decrease the supply of FC toward the enzyme, acyl-coenzyme A:cholesterol acyitransferase, by trapping it in phospholipid-containing pools. {Arteriosclerosis and Thrombosis 1991;11:146-153) F oam cells in atherosclerotic lesions contain large amounts of cholesterol esters. There is considerable evidence that a substantial part of these foam cells originate from monocyte-derived macrophages.
F oam cells in atherosclerotic lesions contain
large amounts of cholesterol esters. There is considerable evidence that a substantial part of these foam cells originate from monocyte-derived macrophages. 1 -4 Macrophages cultured in vitro are able to accumulate cholesterol esters from /3-very low density lipoprotein (/3-VLDL) or from various forms of modified low density lipoproteins (LDLs) like acetyl LDL or endothelial-cell-modified LDL. The uptake of these modified LDLs is mediated by the so-called scavenger receptor, 5 -8 while uptake of 0-VLDL occurs by way of a low-affinity LDL receptor. 9 Both receptors seem to be resistant to downregulation by loading the cells with cholesterol. 5 Vastatins are the collective name for the class of 3-hydroxy-3-methylglutaryl coenzyme A (HMG- 11 They are efficacious in lowering the plasma LDL level, 12 which is brought about by a reduction in cholesterol synthesis and by an increased receptormediated uptake and degradation of LDL in the liver. 13 By lowering the LDL level in plasma, these drugs are probably effective antiatherosclerotic agents.
So far, the direct effect of vastatins on cholesterol ester accumulation in macrophages has not been described. It was the purpose of this study, therefore, to examine whether vastatins are able to interfere with cholesterol ester formation and accumulation in macrophages induced by incubation with acetyl LDL and /3-VLDL.
simvastatin were supplied by A. Alberts, Merck Sharp & Dohme, Rahway, N.J. Pravastatin (CS -514) was donated by Y. Tsujita, Sankyo Co., Tokyo, Japan. The compounds were used as supplied (i.e., all in the lactone form except pravastatin, which was supplied as a sodium salt).
Serum and Lipoproteins
Human inactivated sterilized serum was obtained from the blood bank of the Academic Hospital Leiden. It was stored at -20°C. LDL was obtained from fresh human serum by density gradient ultracentrifugation. 14 The LDL band, conspicuous by its yellow-orange color, was aspirated and confirmed to have d=1.030-1.050 g/ml. LDL was acetylated by repeated addition of acetic anhydride as described. 15 On agarose electrophoresis, the preparation showed a single band with a-mobility.
0-VLDL (d< 1.006) was isolated by ultracentrifugation from serum of a rabbit fed a diet containing 0.5% cholesterol for 2 months. The rabbit 0-VLDL had a cholesterol ester/triglyceride ratio of 1.23:1 mol/mol and showed /3-mobility on electrophoresis. LDL or acetyl LDL was labeled with 125 I as described by Bilheimer et al. 16 Lipoproteins were dialyzed overnight against Medium 199 (M199) and then passed through a 0.22-/xm filter before they were added to cultured macrophages.
Cells
Macrophages were obtained by culturing human monocytes from healthy volunteers, essentially as described by Boyum. 17 Briefly, the cells were isolated from buffy coats obtained from the blood bank of the Academic Hospital Leiden. The buffy coat cells were layered on Ficoll-Paque, Pharmacia, Uppsala, Sweden {d=\.Qtll g/ml) and centrifuged for 30 minutes at 50Qg at room temperature. The cells at the interface were collected and washed twice with phosphatebuffered saline (PBS), pH 7.4, and then resuspended in M199 containing 20% human serum, 100 units/ml penicillin, and 100 /ig/ml streptomycin to a concentration of 10 7 cells/ml. The cell suspension, consisting mainly of lymphocytes and monocytes, was placed in plastic culture dishes (Costar, Cambridge, Mass., containing six wells of 3.5-cm diameter per tray) and incubated for 2 hours at 37°C in a humidified atmosphere containing 95% air/5% CO 2 to allow the monocytes to adhere to the plastic. The nonadherent cells were removed by washing twice with warm M199. The adherent cells were further incubated in M199 with 20% human serum and antibiotics. The medium was refreshed every 2 days until the cells were used in experiments at moments specified in the "Results" section. The standard format for our experiments consisted of incubation for 48 hours in M199 containing 1% (wt/vol) human serum albumin. As specified in the "Results" section, lipoproteins (100 /ig protein/ml) and vastatins (with dimethyl sulfoxide as a solvent, final concentration of 0.1% vol/vol) were added to the incubation media.
Assays
During or after this incubation of 48 hours, various assays were performed.
Rate of cholesterol ester formation. One tenth microcurie (3.73 kBq) [l- 14 C]oleate (Amersham, 59 Ci/mol) was added to the medium, together with unlabeled oleate and complexed with fatty acid-free human serum albumin to a final concentration of 0.05 mM. Incubation was continued in an airtight box filled with 95% air/5% CO 2 at 37°C for 4 hours, after which time the medium was discarded. The cells were washed twice with PBS and harvested by scraping in 1 ml PBS. The cell suspension was homogenized by repeated pipetting through a narrow-bore tip. After removal of aliquots for protein determination by the method of Lowry et al, 18 the homogenates were mixed with 4.5 ml chloroform: methanol (1 : 2 vol/vol) for lipid extraction by the method of Bligh and Dyer. 19 The chloroform layer was brought to dryness, and the total lipid extract of each homogenate was spotted on a 20x20 -cm thinlayer chromatography plate of silica (art. No. 5721, Merck, Darmstadt, F.R.G.), which was first developed for 8 cm in a mixture of chloroform: methanol (98:2 vol/vol) and then for 18 cm in hexane: chloroform (65:45 vol/vol). 14 C-labeled authentic cholesterol oleate (Amersham) was spotted as a reference at the edges and in the middle of the plate. After development, the dried plates were covered with Kodak XAR-5 film for autoradiographic localization of the radioactive spots. The labeled cholesterol oleate spots were identified and scraped for liquid scintillation counting.
Activity of acyl-CoA cholesterol acyltransferase (ACAT).
After the experimental incubation in the presence of acetyl LDL, the cells were washed and homogenized in PBS containing 10 mM dithiothreitol by pipetting through a narrow-bore tip. The assay mix for the ACAT reaction consisted of 1 ml 0.1 M phosphate buffer, pH 7.4, containing 0.2% bovine serum albumin, 20 nmoles oleoylCo A with 0.1 p.Ci [l- 14 C]oleoylCo A (Amersham). After addition of 150 /xg cell homogenate, the mixture was incubated for 5 minutes at 37°C. The reaction was stopped by addition of 4.5 ml chloroform: methanol (1:2 vol/vol) for lipid extraction, and the extract was subjected to thin-layer chromatography as described above. The radioactivity in the cholesterol ester spot was determined by liquid scintillation counting.
Rate of cholesterol synthesis. The cells were incubated with or without lipoproteins and vastatins for 48 hours in the presence of 0.
Ci/mol), and cells were extracted as above. The lipid extract was saponified in alkaline ethanol for 60 minutes at 60°C. After addition of 1 ml distilled water, the nonsaponifiable lipids were extracted twice with 2 ml hexane. The hexane layers were combined, backextracted with water, and mixed with scintillation fluid. The radioactivity was confirmed to be present in cholesterol by thin-layer chromatography.
Rate of phospholipid synthesis. Four tenths microcuries [methyl-
u C]cho\ine (Amersham, 55 Ci/mol) was added to the cells during the 48-hour experimental incubation. The incorporation of label in phosphatidylcholine and sphingomyelin was measured by spotting the lipid extract on the same thin-layer plates as above, which were then developed in chloroform : methanol: water (75^25:2 vol/vol/vol). The plates were exposed to Kodak XAR-5 film to identify the phospholipid spots. These were then scraped and counted as described above.
Cellular mass of free cholesterol and cholesterol ester.
After the experimental incubation period, the medium was removed, and the cells were washed twice with PBS, scraped in PBS, homogenized, and divided in two equal parts, one part being saponified in ethanolic KOH and the other part left untreated. From both parts, the sterols were then collected in hexane, which was brought to dryness under nitrogen. The lipid residues were dissolved in 100 jtl ethanol and assayed for free cholesterol using the method of Gamble et al. 20 The difference between cholesterol in the saponified and the nonsaponified samples was taken to represent cholesterol ester.
Association and degradation of 123
I-labeled low density lipoprotein or acetyl low density lipoprotein. After the experimental incubation period, the cells were washed with M199 and 1% human serum albumin and then incubated in this medium for 3 hours at 37°C with 10^g/ml (protein) of labeled lipoprotein with or without an excess (500 /xg/ml protein) of unlabeled lipoprotein. Thereafter, the medium was aspirated and analyzed for cell-mediated degradation. 21 After aspiration of the medium, the cells were cooled on ice and scraped in 1 ml ice-cold PBS containing 0.2% serum albumin. The suspension was centrifuged (model Microfuge B, Beckman, Palo Alto, Calif.), and the pellet washed twice in PBS without albumin. The pellet was then taken up in 0.5 ml 0.1 M NaOH to assess the cell-associated radioactivity and the amount of cell protein. Association and degradation data for the incubations with excess unlabeled lipoprotein were subtracted from those for the incubations with only labeled lipoprotein, yielding an estimate of the receptor-mediated association and degradation.
Statistics
Incubations were always performed in triplicate. Student's t test for unpaired data was used to judge whether differences were statistically significant (/7<O.O5).
Results
To confirm that the monocytes placed in culture were indeed converted in macrophages, the accumulation of free and esterified cholesterol was assessed after incubation with native or acetylated LDL. The cells were found to contain more cholesterol ester after 48 hours' incubation with acetylated LDL than with native LDL, the difference between these two 
Cpt, compactin; LDL, low density lipoproteins; 0-VLDL, 0-very low density lipoproteins.
•Significantly different from incubation without compactin.
increasing with the age of the culture (results not shown). This is in line with the fall in LDL-receptor activity and rise in scavenger-receptor activity that have been reported to occur during differentiation of monocytes into macrophages. 622 Further experiments were done with macrophages kept for 5 days in culture in M199 with 20% human serum.
As the first-discovered representative of the vastatins, the compound mevastatin, denoted further on as compactin, was studied. It is shown in Table 1 that incubation in the presence of 5 ^g/ml compactin had no significant effect on the cellular content of either free or esterified cholesterol. In the presence of LDL, compactin caused a small increase in free cholesterol but did not affect the content of cholesterol ester. The accumulation of cholesterol ester induced by acetyl LDL was markedly diminished by simultaneous addition of compactin. In contrast, the rise in free cholesterol caused by acetyl LDL was further increased by compactin. Compactin also reduced the accumulation of cholesterol ester and enhanced that of free cholesterol brought about by /3-VLDL, although this effect was not as pronounced as with acetyl LDL. These findings prompted us to examine whether these effects could be ascribed to inhibition of the cholesterol esterification process, as mediated by the enzyme ACAT. Accordingly, we measured the incorporation of labeled oleate into the cholesterol ester fraction after incubating the cells under the same conditions as in the experiment of Table 1 . The results are presented in Figure 1 . As shown here, incubation of the cells with compactin alone already led to a decreased oleate incorporation. Incubation with LDL had almost no effect, whereas addition of acetyl LDL or /3-VLDL caused a marked stimulation of the ACAT-mediated process. Simultaneous addition of compactin in all these instances led to a significantly reduced cholesterol ester formation as compared with the no-drug control. The inhibition caused by compactin was smaller in the case of )3-VLDL than in that of acetyl LDL. In another experiment, the induction of cholesterol ester formation using copper-oxidized LDL (LDL dialyzed for 16 hours against 25 ^M CuSO 4 ) was also strongly inhibited by the simultaneous presence of compactin (results not shown).
Compactin, as well as other vastatins, was tested in increasing concentrations for its effect on cholesterol ester formation in the presence of acetyl LDL. The concentration of compactin needed for half-maximal suppression was about 30 ng/ml (Figure 2) . In comparison with compactin, lovastatin and simvastatin were clearly more potent, whereas pravastatin was about 100-fold less effective (Figure 2) .
We wondered whether this block in cholesterol ester formation was secondary to a block in cholesterol synthesis due to inhibition of HMG-CoA reductase. As shown in Table 2 , it was found that in macrophages incubated with 5 jig/ml compactin alone, cholesterol synthesis (assessed by [ M C]acetate incorporation in cholesterol) was inhibited by 90%. Incubation with acetyl LDL (100 jig/ml) caused the same extent of inhibition, but compactin was still able to further suppress cholesterol synthesis.
A hypothetical mode by which compactin could reduce ACAT-mediated cholesterol ester accumulation induced by acetyl LDL might be a decrease in the receptor-mediated uptake of acetyl LDL. After incubation with compactin alone, with acetyl LDL, or with both compounds, macrophages displayed the same amount of receptor-mediated association of acetyl LDL (Figure 3) . The rate of degradation of acetyl LDL was somewhat lowered in the cells incubated with compactin, but this effect was not statistically significant when acetyl LDL was also present during the 48-hour incubation. In contrast, treatment of the cells with compactin led to a marked increase of the receptor-mediated association and degradation of native LDL (results not shown).
Another mechanism that might explain the reduction of cholesterol ester accumulation caused by compactin could be an enhanced release of cholesterol from the cells to the medium. To assess this, macrophages were first loaded with cholesterol ester by incubation with acetyl LDL and then incubated for 24 or 48 hours in the absence of any lipoprotein and with or without compactin. As shown in Figure 4 , the cellular cholesterol ester content decreased while the content of free cholesterol first fell and then increased again during the postincubation period. The presence of compactin did not change this pattern.
The results described so far indicated that vastatins blocked the ACAT-mediated cholesterol ester synthesis in cultured macrophages. Next, we tested whether these drugs were able to inhibit the ACAT reaction when directly added to a cell-free assay system containing homogenized macrophages (first cultured in the presence of acetyl LDL) as a source of enzyme and of free cholesterol. No effect was observed with compactin added to the assay mixture in concentrations of up to 5 p.g/ml (results not shown). Neither had compactin an effect on the ACAT activity in isolated rat liver microsomes (results not shown).
Finally, we examined the possibility of whether compactin would stimulate the synthesis of phospholipids (phosphatidylcholine or sphingomyelin), as these might trap free cholesterol in the cell and thus make less cholesterol available for ACATmediated esterification. Incubation of the cells with compactin did not affect the incorporation of [ 
Discussion
The data allow us to conclude that in macrophages, compactin and other vastatins are able to suppress the cholesterol ester formation induced by incubation with modified LDL or £-VLDL. The difference in efficacy observed between the various vastatins with respect to the inhibition of cholesterol ester synthesis is comparable to the findings of Tsujita et al 23 and Mosley et al, 24 who found that pravastatin is much less potent than compactin, 23 or lovastatin and simvastatin 24 in inhibiting cholesterol synthesis in various rat cells or tissues. 10,251±617 549±34' 319±18 6±6* Cells were cultured for 5 days in Medium 199 (M199) with 20% human serum and then for 48 hours in M199 with human serum albumin with or without compactin (5 jig/ml) or acetyl LDL (100 ALg/ml). Values are mean±SD for three wells.
Although compactin was still able to suppress cholesterol synthesis under these conditions, it is unlikely that the effect on cholesterol ester formation is related to inhibition of cholesterol synthesis since cholesterol synthesis in the presence of acetyl LDL was already very low. Neither can the effect be attributed to a decrease in receptor-mediated uptake or degradation of acetyl LDL since such a decrease did not occur (Figure 3 ). This lack of effect might be expected in view of the earlier observation that the activity of the scavenger receptor is also not influenced by loading the cells with cholesterol.
5
- 25 In contrast, compactin treatment led to an increased activity of the LDL receptor as shown previously by others. 26 The best explanation of the present findings is that the vastatins inhibit the ACAT reaction in macrophages. This is indicated by the reduced incorporation of labeled oleate in cholesterol ester in the vastatin-treated cells, occurring even when no exogenous cholesterol was added (Figure 1 ). However, compactin had no direct inhibitory effect in the cell-free ACAT assay, in the concentrations at which it clearly blocked cholesterol ester formation in the cells. Therefore, it must be inferred that vastatin treatment in some way decreases the flow of free cholesterol toward the substrate site of the enzyme 
Association Degradation
ACAT. This effect is clearly not an immediate one since we observed no effect in the cell-free system. In the intact cells, it might be the result of interference with interorganelle transport of free cholesterol (as recently described for the compound U18666A, 27 another inhibitor of cholesterol synthesis) or of trapping cholesterol in membranous structures that are not in contact with the ACAT site. Although we did indeed find that compactin induced phospholipid synthesis when the incubation was done in the presence of acetyl LDL ( Figure 5 ), further experiments are needed to test these hypotheses. Recently, it has been reported that simvastatin is able to decrease the intestinal absorption of free cholesterol in cholesterol-fed rabbits 28 and that the acid forms of both lovastatin and simvastatin act as inhibitors of ACAT activity in microsomes of the rabbit intestine, 29 with half-maximal inhibitory concentrations on the order of 10 5 M. These findings are in line with other data that true ACAT inhibitors can decrease cholesterol absorption. 30 More recently, lovastatin was reported to block the transport of labeled cholesterol through a monolayer of CaCo-2 cells, a model of human small intestinal mucosal cells, 31 in parallel with a decrease in the incorporation of oleate in cholesterol esters.
It remains to be seen in future in vivo studies whether the direct effect on cholesterol ester formation by vastatins as described here might play a role in retarding or preventing development of foam cells and atherosclerosis. •a of Minister, B.R.D., for suggesting to us a study of the effect of compactin on phospholipid synthesis.
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